Personalizing the supply chain
Executing the logistics of cell and gene therapies is a challenge like no other—after all, if you cannot deliver the therapy to the patient, its efficacy is irrelevant, as the patient receives no benefit. For your patients, the stakes have never been higher. As your logistics partner, our record of flawless execution has never been more valuable. Discover how to partner with World Courier and access our global logistics platform.
Managing ultra-complex timing
Flawless planning and execution
Because cell and gene therapies involve living cells there can be extremely limited shelf lives, so timely transport is, quite plainly, a matter of life or death. Collaborative assessment and study design are just the beginning. We partner with key stakeholders in study-specific SOPs, extensive contingency planning and transparency to ensure unexpected complications don’t impact your delivery. Some might call it excessive. We call it reliability your research and patients can trust.
Logistics: scale from clinical to commercial
As cell and gene therapies move through clinical trials and advance toward a commercial launch, innovators must overcome unprecedented challenges. In many cases, this will require redefining established approaches within many areas of commercialization. Together with industry-leading partners across the AmerisourceBergen enterprise, we offer end-to-end commercialization strategies for making this new, patient-centered logistics model scalable.
In a recent phase II cell therapy study, we delivered:
on-time delivery TO SITES
Helping realize the promise of cell and gene therapies
Leveraging the power of our global network
Best-in-class temperature control solutions
Unmatched temperature stability
In the world of cell and gene therapy transport, success requires diverse, reliable solutions. A single treatment might require both controlled-ambient and cryogenically-frozen shipments within the same supply loop. With empirically-backed expertise in all conditions for shipping, we can build a robust and flexible partnership with your clinical and commercial operations team to create truly customized temperature-controlled shipping solutions that help patients access life-changing treatment.
Quality beyond compliance
Industry-defining GxP standards
Quality begins with strict adherence to global GxP standards. But for these highly-complex, high-value shipments, there is zero room for deviation or failure. Cell and gene therapies must also comply with even more stringent cGMP regulations. We strive for ‘quality beyond compliance’ at the global level to ensure even greater attention to detail and a single-minded focus on perfection.
Reaching targeted populations
A human network with a global reach
Because cell and gene therapies often treat rare diseases with small patient populations, studies are scaling out to involve patients from around the world. With our global network of 140+ owned offices in more than 50 countries, only World Courier can support your research and commercial needs, wherever the patient is located.
Partnerships built on experience
What do we bring to a partnership? In a word, ‘experience.’ Experience in all the areas that extend beyond the patient or microscope and are not innate to the clinical team. Experience with airlines and customs in every part of the world. With permits and licensing requirements in a dynamic global regulatory environment. As a partner in your study, we bring experience managing thousands of details to enable the successful completion of every shipment.